Metabolic and genetic influence on glucose metabolism in type 2 diabetic subjects - Experiences from relatives and twin studies

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 17, Issue 3, 2003, Pages 445-467

  Beck Nielsen, Henning ^a   Vaag, Allan ^b   Poulsen, Pernille ^c   Gaster, Michael ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b STENO DIABETES CENTER   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Glucose intolerance; Glycogen synthase; Insulin deficiency; Insulin resistance; Intrauterine malnutrition; Obesity; Twins; Type 2 diabetes

Indexed keywords

ACYL COENZYME A; FATTY ACID; GLUCOSE; GLYCOGEN; GLYCOGEN SYNTHASE; INSULIN; INSULIN RECEPTOR KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; TRIACYLGLYCEROL; GASTROINTESTINAL HORMONE;

ALLELE; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENETIC PARAMETERS; GENETIC PREDISPOSITION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; HUMAN; HYPERGLYCEMIA; INHERITANCE; INSULIN RELEASE; INSULIN RESISTANCE; MALNUTRITION; METABOLIC PARAMETERS; MOLECULAR BIOLOGY; MONOZYGOTIC TWINS; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; RELATIVE; REVIEW; SIGNAL TRANSDUCTION; TWINS; ADIPOSE TISSUE; B LYMPHOCYTE; DISEASE COURSE; GENETIC DISORDER; GENETIC EPIDEMIOLOGY; GLUCONEOGENESIS; HEREDITY; LIVER METABOLISM; METABOLIC DISORDER; MUSCLE METABOLISM; SKELETAL MUSCLE;

EID: 0141678155     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-690X(03)00041-1     Document Type: Review

References (84)

1. Beck-Nielsen H & Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1994; 94: 1714-1721.
2. Beck-Nielsen H & Hother-Nielsen O. Obesity in type 2 diabetes mellitus. In LeRoith D, Taylor SI & Olefsky JM (eds) Diabetes Mellitus. A Fundamental and Clinical Text. Philadelphia: Lippincott Williams & Wilkins, 2000, pp. 567-575.
3. Hales CN, Barker DJ, Clark PM et al. Fetal and infant growth and impaired glucose tolerance at age 64. British Medical Journal 1991; 303: 1019-1022.
4. Harvald B & Hauge M. Hereditary factors elucidated by twin studies. In Neel JV, et al. (eds) Genetics and the Epidemiology of Chronic Diseases. Washington, DC: Department of Health, Education and Welfare, 1965, pp. 61-76.
5. Poulsen P, Kyvik KO, Vaag A & Beck-Nielsen H. Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance - A population-based twin study. Diabetologia 1999; 42: 139-145.
6. Neale MC & Cardon LR. Data Summary. Methodology for Genetic Studies of Twins and Families. NATO ASI Series. Dordrecht: Kluwer, 1992, pp. 35-53.
7. Tattersall RB & Pyke DA. Diabetes in identical twins. Lancet 1972; ii: 1120-1125.
8. Commmittee on diabetic twins JDS, Diabetes mellitus in twins: A cooperative study in Japan. Diabetes Research Clinical Practice 1988; 5: 271-280.
9. Newman B, SELBY JV, King MC et al. Concordance for type 2 (non-insulin-dependent) diabetis mellitus in male twins. Diabetologia 1987; 30: 763-768.
10. Barnett AH, Eff C, Leslie RD & Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981; 20: 87-93.
11. Kaprio J, Tuomilehto J, Koskenvuo M et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992; 35: 1060-1067.
12. Newman B, Selby JV, King MC et al. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987; 30: 763-768.
13. Kobberling J & Tillil H. Empirical risk figures for first-degree relatives of non-insulin dependent diabetics. Academic Press Seronto Symposium No. 47 'The Genetics of Diabetes Mellitus', 1982.
14. Poulsen P, Vaag A, Kyvik K & Beck-Nielsen H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 2001; 44: 537-543.
15. Hong Y, Pedersen NL, Brismar K & De Faire U. Genetic and environmental architecture of the features of the insulin-resistance syndrome. American Journal of Human Genetics 1997; 60: 143-152.
16. Mayer EJ, Newman B, Austin MA et al. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: An analysis of women twins. American Journal of Epidemiology 1996; 143: 323-332.
17. Bouchard C, Tremblay A, Despres JP et al. The response to long-term overfeeding in identical twins. New England Journal of Medicine 1990; 322: 1477-1482.
18. Selby JV, Newman B, Quesenberry Jr. CP et al. Genetic and behavioral influences on body fat distribution. International Journal of Obesity and Related Metabolic Disorders 1990; 14: 593-602.
19. Cardon LR, Carmelli D, Fabsitz RR & Reed T. Genetic and environmental correlations between obesity and body fat distribution in adult male twins. Human Biology 1994; 66: 465-479.
20. Poulsen P, Vaag AA, Kyvik KO et al. Low birth weight is associated with NIDDM in discordant monozygotic and dizygotic twin pairs. Diabetologia 1997; 40: 439-446.
21. Phipps K, Barker DJ, Hales CN et al. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36: 225-228.
22. Phillips DI, Hirst S, Clark PM et al. Fetal growth and insulin secretion in adult life. Diabetologia 1994; 37: 592-596.
23. Phillips DI. Twin studies in medical research: Can they tell us whether diseases are genetically determined? Lancet 1993; 341: 1008-1009.
24. Ramos-Arroyo MA, Ulbright TM, Yu PL & Christian JC. Twin study: Relationship between birth weight, zygosity, placentation, and pathologic placental changes. Acta Geneticae Medicae Gemellol (Roma) 1988; 37: 229-238.
25. Naeye RL. The fetal and neonatal development of twins. Pediatrics 1964; 33: 546-549.
26. McDonald AM. Twin studies in medical research. Lancet 1993; 341: 1419.
27. Poulsen P, Vaag A & Beck-Nielsen H. Does zygosity influence the metabolic profile of twins? A population based cross sectional study. British Medical Journal 1999; 319: 151-154.
28. Poulsen P, Levin K, Beck-Nielsen H & Vaag A. Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia 2002; 45: 1649-1657.
29. Christiansen C, Poulsen P & Beck-Nielsen H. The Trp64Arg mutation of the adrenergic beta-3 receptor gene impairs insulin secretion: A twin study. Diabetic Medicine 1999; 16: 835-840.
30. Fenger M, Poulsen P, Beck-Nielsen H & Vaag A. Impact of the Xba 1-polymorphism of the human muscle glycogen synthase gene on parameters of the insulin resistance syndrome in a Danish twin population. Diabetic Medicine 2000; 17: 735-740.
31. Bentzen J, Poulsen P, Vaag A et al. The influence of the polymorphism in apolipoprotein B codon 2488 on insulin and lipid levels in a Danish twin population. Diabetic Medicine 2002; 19: 12-18.
32. Poulsen P, Andersen G, Fenger M et al. Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: Thrifty genotype, thrifty phenotype, or both? Diabetes 2003; 52: 194-198.
33. Yki-Jäsrvinen H. Glucose toxicity. Endocrine Reviews 1992; 13: 415-431.
34. Nyholm B, Oestergaard T, Vaag A & Schmitz O. What have metabolic studies in healthy relatives taught us about the pathogenesis of type 2 diabetes? In Walker M et al. (eds) The Diabetes Annual, 2000.
35. Kahn CR. Insulin resistance: A common feature of diabetes mellitus (editorial). New England Journal of Medicine 1986; 315: 252-2354.
36. Vaag A, Heriksen JE & Beck-Nielsen H. Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1992; 89: 782-788.
37. Vaag A, Henriksen JE, Madsbad S et al. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. Journal of Clinical Investigation 1995; 95: 690-698.
38. Vaag A, Alford F & Beck-Nielsen H. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): Acquired versus genetic metabolic defects? Diabetic Medicine 1996; 13: 806-815.
39. Pimenta W, Korytkowski M, Mitrakou A et al. Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. Journal of the American Medical Association 1995; 273: 1855-1861.
40. Alcolado JC & Alcolado R. Importance of maternal history of non-insulin dependent diabetic patients. British Medical Journal 1991; 302: 1178-1180.
41. Humphriss DB, Stewart MW, Berrish TS et al. Multiple metabolic abnormalities in normal glucose tolerance relatives of NIDDM families. Diabetologia 1997; 40: 1185-1190.
42. Migdalis IN, Zachariadis D, Kalogeropoulou K et al. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus. Diabetic Medicine 1996; 13: 434-440.
43. Perseghin G, Ghosh S, Gerow K & Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents: A cross-sectional study. Diabetes 1997; 46: 1001-1009.
44. Vaag A, Lehtovirta M, Thye-Ronn P & Groop L. Metabolic impact of a family history of type 2 diabetes. Results from a European multicentre study (EGIR). Diabetic Medicine 2001; 18: 533-540.
45. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nature Genetics 2000; 26: 76-80.
46. Ek J, Andersen G, Urhammer SA et al. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians. Diabetologia 2001; 44: 1170-1176.
47. Ek J, Andersen G, Urhammer SA et al. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-I) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 2001; 44: 2220-2226.
48. Bjorbaek C, Echwald SM, Hubricht P et al. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes 1994; 43: 976-983.
49. Almind K, Bjorbaek C, Vestergaard H et al. Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342: 828-832.
50. Eriksson J, Franssila-Kallunki A, Ekstrand A et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. New England Journal of Medicine 1989; 321: 337-343.
51. Schalin-Jantti C, Harkonen M & Groop LC. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 1992; 41: 598-604.
52. Henry RR, Ciaraldi TP, Abrams-Carter L et al. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. Journal of Clinical Investigation 1996; 98: 1231-1236.
53. Wells AM, Sutcliffe IC, Johnson AB & Taylor R. Abnormal activation of glycogen synthesis in fibroblasts from NIDDM subjects. Evidence for an abnormality specific to glucose metabolism. Diabetes 1993; 42: 583-589.
54. Gaster M, Petersen I, Hojlund K et al. The diabetic phenotype is conserved in myotubes established from diabetic subjects: Evidence for primary defects in glucose transport and glycogen synthase activity. Diabetes 2002; 51: 921-927.
55. Hojlund K, Staehr P & Hansen BF. Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes. Diabetes 2003; in press.
56. Rothman DL, Magnusson I, Cline G et al. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proceedings of the National Academy of Sciences of the USA 1995; 92: 983-987.
57. Price TB, Perseghin G, Duleba A et al. NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise. Proceedings of the National Academy of Sciences of the USA 1996; 93: 5329-5334.
58. Perseghin G, Price TB, Petersen KF et al. Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects. New England Journal of Medicine 1996; 335: 1357-1362.
59. Meyer MM, Levin K, Grimmsmann T et al. Insulin signalling in human skeletal muscle of subjects with or without type II-diabetes and first degree relatives of patients with the disease. Diabetologia 2002; 45: 813-822.
60. Storgaard H, Song XM, Jensen CB et al. Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients (corrected). Diabetes 2001; 50: 2770-2778.
61. Colwell JA & Lein A. Diminished insulin response to hyperglycemia in prediabetes and diabetes. Diabetes 1967; 16: 560-565.
62. Soeldner JS, Gleason RE, Williams RF et al. Diminished serum insulin response to glucose in genetic prediabetic males with normal glucose tolerance. Diabetes 1968; 17: 17-26.
63. Fernandez-Castaner M, Biarnes J, Camps I et al. Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus. Diabetic Medicine 1996; 13: 953-959.
64. Schmitz O, Porksen N, Nyholm B et al. Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM. American Journal of Physiology 1997; 272: E218-E226.
65. Beck-Nielsen H, Hother-Nielsen O, Vaag A & Alford F. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: The role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment. Diabetologia 1994; 37: 217-221.
66. La Barre J. Sur les possibilités d'un traitement du diabetes par l'incretine. Bulletin Academie Royale de Medecine Belge 1932; 12: 620-634.
67. Orskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 1992; 35: 701-711.
68. Gaster M, Beck-Nielsen H & Schroder HD. Proliferation conditions for human satellite cells. The fractional content of satellite cells. APMIS 2001; 109: 726-734.
69. Gaster M, Kristensen SR, Beck-Nielsen H & Schroder HD. A cellular model system of differentiated human myotubes. APMIS 2001; 109: 735-744.
70. Henry RR, Abrams L, Nikoulina S & Ciaraldi TP. Insulin action and glucose metabolism in nondiabetic control and NIDDM subjects. Comparison using human skeletal muscle cell cultures. Diabetes 1995; 44: 936-946.
71. Gaster M, Schroder HD, Handberg A & Beck-Nielsen H. The basal kinetic parameters of glycogen synthase in human myotube cultures are not affected by chronic high insulin exposure. Biochimica et Biophysica Acta 2001; 1537: 211-221.
72. Krutzfeldt J, Kausch C, Volk A et al. Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes 2000; 49: 992-998.
73. Vollenweider P, Menard B & Nicod P. Insulin resistance, defective insulin receptor substrate 2-associated phosphatidylinositol-3prime; kinase activation, and impaired atypical protein kinase C (zeta/lambda) activation in myotubes from obese patients with impaired glucose tolerance. Diabetes 2002; 51: 1052-1059.
74. Thompson DB, Pratley R & Ossowski V. Human primary myoblast cell cultures from non-diabetic insulin resistant subjects retain defects in insulin action. Journal of Clinical Investigation 1996; 98: 2346-2350.
75. Hales CN & Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992; 35: 595-601.
76. Jensen CB, Storgaard H, Dela F et al. Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes 2002; 51: 1271-1280.
77. Phillips DI, Barker DJ, Hales CN et al. Thinness at birth and insulin resistance in adult life. Diabetologia 1994; 37: 150-154.
78. Boden G, Jadali F, White J et al. Effects of fat on insulin-stimulated carbohydrate metabolism in normal men. Journal of Clinical Investigation 1991; 88: 960-966.
79. Lewis GF, Carpentier A, Adeli K & Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Reviews 2002; 23: 201-229.
80. Kelly DE & Mandarino LJ. Fuel selection in human skeletal muscle in insulin resistance: A reexamination. Diabetes 2000; 49: 677-683.
81. Randle PJ, Garland PB, Hales CN & Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785-789.
82. Damsbo P, Vaag A, Hother-Nielsen O & Beck-Nielsen H. Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991; 34: 239-245.
83. Shulman GI. Cellular mechanisms of insulin resistance. Journal of Clinical Investigation 2000; 106: 171-176.
84. Garg A & Misra A. Hepatic steatosis, insulin resistance, and adipose tissue disorders. Journal of Clinical Endocrinology and Metabolism 2002; 87: 3019-3022.